Online citations, reference lists, and bibliographies.

Mucinous Carcinoma Of The Ovary

J. Brown, M. Frumovitz
Published 2017 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Mucinous ovarian carcinoma is a rare tumor, but deserves separate attention, as its clinical behavior is quite different from other types of ovarian carcinoma. This has implications for both surgical therapy as well as adjuvant treatment.
This paper references
10.1097/PAS.0000000000000553
SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type
Michelle Moh (2016)
10.1016/j.ajog.2013.02.046
The risk of adverse pregnancy outcome after bariatric surgery: a nationwide register-based matched cohort study.
M. M. Kjær (2013)
10.1097/AOG.0b013e3181e7961d
Prevalence of Lymph Node Metastasis in Primary Mucinous Carcinoma of the Ovary
K. Schmeler (2010)
10.1086/318787
Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.
H. Risch (2001)
10.6004/JNCCN.2013.0142
Ovarian cancer, version 2.2013: Featured updates to the NCCN guidelines
R. Morgan (2013)
10.1038/sj.bjc.6603003
A distinct molecular profile associated with mucinous epithelial ovarian cancer
V. Heinzelmann-Schwarz (2006)
10.1093/JNCI/92.9.699
Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results.
M. Piccart (2000)
10.1016/S1470-2045(11)70058-4
Mucinous carcinomas of the ovary and colorectum: different organ, same dilemma.
L. Kelemen (2011)
10.4143/crt.2014.004
Safety of Fertility-Sparing Surgery in Primary Mucinous Carcinoma of the Ovary
Jung-Yun Lee (2015)
10.1200/JCO.2006.10.2517
Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study.
W. Winter (2007)
10.1016/S0090-8258(03)00264-6
Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma.
M. Gemignani (2003)
10.1186/1471-2407-9-433
HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy
J. McAlpine (2009)
10.1016/J.YGYNO.2004.12.056
Advanced stage mucinous epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
D. Pectasides (2005)
10.1097/01.pgp.0000101080.35393.16
The Histologic Type and Stage Distribution of Ovarian Carcinomas of Surface Epithelial Origin
J. Seidman (2004)
10.1016/j.ajog.2012.10.863
The role of appendectomy for mucinous ovarian neoplasms.
J. E. Lin (2013)
10.1053/j.seminoncol.2008.10.009
Pathologic evaluation of unknown primary cancer.
K. Oien (2009)
10.1093/annonc/mdq257
Mucinous advanced epithelial ovarian carcinoma: clinical presentation and sensitivity to platinum-paclitaxel-based chemotherapy, the GINECO experience.
J. Alexandre (2010)
10.1097/01.pas.0000213281.43036.bb
Cytokeratins 7 and 20 in Primary and Secondary Mucinous Tumors of the Ovary: Analysis of Coordinate Immunohistochemical Expression Profiles and Staining Distribution in 179 Cases
R. Vang (2006)
10.1200/JCO.2008.19.1684
Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup.
M. Bookman (2009)
10.1056/NEJM199601043340101
Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer.
W. Mcguire (1996)
10.1097/00000478-200212000-00001
Diagnostic Criteria and Behavior of Ovarian Seromucinous (Endocervical-Type Mucinous and Mixed Cell-Type) Tumors: Atypical Proliferative (Borderline) Tumors, Intraepithelial, Microinvasive, and Invasive Carcinomas
H. Shappell (2002)
10.1097/IGC.0000000000000473
Survival of Patients With Mucinous Ovarian Carcinoma and Ovarian Metastases: A Population-Based Cancer Registry Study
M. Simons (2015)
10.3892/ijo_00000114
Serous and mucinous ovarian tumors express different profiles of MMP-2, -7, -9, MT1-MMP, and TIMP-1 and -2.
J. Brun (2008)
10.1186/s12885-015-1421-8
Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms
Robertson Mackenzie (2015)
10.1136/jcp.2009.072355
Serum CA19.9 levels are commonly elevated in primary ovarian mucinous tumours but cannot be used to predict the histological subtype
P. Kelly (2010)
10.1016/J.YGYNO.2007.08.085
Laparoscopic surgery for large benign ovarian cysts.
G. Eltabbakh (2008)
10.1200/JCO.2000.18.1.106
Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study.
F. Muggia (2000)
10.1097/PGP.0b013e3181bc2706
Ovarian Intestinal Type Mucinous Borderline Tumors: Are We Ready for a Nomenclature Change?
Andres G Chiesa (2010)
10.1006/GYNO.2002.6805
Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy.
J. Schilder (2002)
10.1016/S1470-2045(12)70322-4
Ovarian cancer and smoking: individual participant meta-analysis including 28 114 women with ovarian cancer from 51 epidemiological studies
V. Beral (2012)
10.1016/0020-7292(90)90378-X
Relative Frequency of Primary Ovarian Neoplasms: A 10-Year Review
P. Koonings (1989)
10.1093/jnci/95.2.105
International Collaborative Ovarian Neoplasm Trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm Trial: Two Parallel Randomized Phase III Trials of Adjuvant Chemotherapy in Patients With Early-Stage Ovarian Carcinoma.
J. Trimbos (2003)
10.1016/j.ygyno.2009.02.010
Clinicopathological characteristics of mucinous adenocarcinoma of the ovary.
M. Shimada (2009)
10.1136/jclinpath-2011-200320
Mucinous tumours of the ovary
Jay D Naik (2011)
10.1111/j.1399-0004.2008.00974.x
Probability of BRCA1/2 mutation varies with ovarian histology: results from screening 442 ovarian cancer families
D. Evans (2008)
10.1200/JCO.20.5.1248
Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis.
R. Bristow (2002)
10.1016/j.ygyno.2010.02.010
Unmasking the complexities of mucinous ovarian carcinoma.
M. Frumovitz (2010)
10.1097/00000478-200307000-00014
Primary and Metastatic Mucinous Adenocarcinomas in the Ovaries: Incidence in Routine Practice With a New Approach to Improve Intraoperative Diagnosis
J. Seidman (2003)
10.1016/J.YGYNO.2006.05.022
Is complete surgical staging necessary in patients with stage I mucinous epithelial ovarian tumors?
Y. Cho (2006)
10.1097/01.PGP.0000139648.17750.35
Expression of Mesothelin, Fascin, and Prostate Stem Cell Antigen in Primary Ovarian Mucinous Tumors and Their Utility in Differentiating Primary Ovarian Mucinous Tumors From Metastatic Pancreatic Mucinous Carcinomas in the Ovary
D. Cao (2005)
10.1097/IGC.0000000000000296
Gynecologic Cancer InterGroup (GCIG) Consensus Review for Mucinous Ovarian Carcinoma
J. Ledermann (2014)
10.1097/00000478-200011000-00001
Mucinous Tumors of the Ovary: A Clinicopathologic Study of 196 Borderline Tumors (of Intestinal Type) and Carcinomas, Including an Evaluation of 11 Cases With `Pseudomyxoma Peritonei'
K. Lee (2000)
10.1111/j.1349-7006.2008.01065.x
Combination chemotherapy of oxaliplatin and 5‐fluorouracil may be an effective regimen for mucinous adenocarcinoma of the ovary: A potential treatment strategy
S. Sato (2009)
10.1186/1471-2407-8-252
Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: results from the SOCRATES retrospective study
S. Pignata (2008)
10.1016/S0140-6736(00)03590-X
Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma
I. Vergote (2001)
10.3322/caac.21166
Cancer statistics, 2013
R. Siegel (2013)
Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy.
S. Mok (1993)
10.1097/00000478-199906000-00001
Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas.
M. Riopel (1999)
10.1016/J.HUMPATH.2006.03.003
Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas.
D. Sarrió (2006)
10.1200/JCO.2004.08.078
Mucinous epithelial ovarian cancer: a separate entity requiring specific treatment.
V. Hess (2004)
A phase II study of combined CPT-11 and mitomycin-C in platinum refractory clear cell and mucinous ovarian carcinoma.
Y. Shimizu (1998)
10.1080/02841860701784544
Survival in ovarian cancer patients by histology and family history
J. Ji (2008)
10.1089/lap.2011.0435
Laparoscopic resection of massive ovarian mucinous cystadenoma.
Charles M. Leys (2012)
10.1002/cncr.24461
Fertility preservation in young women with epithelial ovarian cancer
J. Wright (2009)
10.1158/1078-0432.CCR-08-0523
Analysis of Gene Expression in Early-Stage Ovarian Cancer
S. Marchini (2008)
10.1002/HUMU.10181
TP53 and ovarian cancer
M. Schuijer (2003)
10.1016/j.ygyno.2008.09.043
A serum based analysis of ovarian epithelial tumorigenesis.
B. Nolen (2009)
10.1002/path.4088
Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas.
M. Anglesio (2013)
10.1158/1078-0432.CCR-10-3176
Targeting Src in Mucinous Ovarian Carcinoma
K. Matsuo (2011)
10.3802/jgo.2016.27.e20
Outcomes of laparoscopic fertility-sparing surgery in clinically early-stage epithelial ovarian cancer
Jin-Young Park (2016)
Multicystic ovarian tumor weighing 156 lbs: the second largest tumor in Texas.
D. Tait (1997)
10.4103/0973-1482.92011
Histologic pattern, bilaterality and clinical evaluation of 957 ovarian neoplasms: a 10-year study in a tertiary hospital of eastern India.
S. Mondal (2011)
10.1097/00000478-200303000-00001
The Distinction Between Primary and Metastatic Mucinous Carcinomas of the Ovary: Gross and Histologic Findings in 50 Cases
K. Lee (2003)
10.1097/00000478-200202000-00001
Mucinous Tumors of the Ovary: A Clinicopathologic Analysis of 75 Borderline Tumors (of Intestinal Type) and Carcinomas
I. Rodríguez (2002)
10.1111/IGC.0b013e3181dd0110
Prognostic Relevance of Uncommon Ovarian Histology in Women With Stage III/IV Epithelial Ovarian Cancer
H. Mackay (2010)



Semantic Scholar Logo Some data provided by SemanticScholar